STAT+: GE HealthCare CEO named chair of medical device lobby AdvaMed’s new imaging division
AdvaMed named Peter Arduini, CEO of GE HealthCare, chair of its board of directors on…
Category: Medicine
.jpg)
STAT+: NEJM aims to hold AI to account with new publication
One of the most prestigious names in medical publishing is going all in on artificial…
Morning Rounds: Preterm birth rates vary across the U.S., with the highest in the Southeast
Understand how science, health policy, and medicine shape the world everyday. Sign up for our…
The biotech news you missed from the weekend
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Pharmalittle: Bluebird’s sickle-cell screwups may prompt a sale; drugmakers raised prices on widely used meds without new clinical evidence
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
STAT+: The prices of 8 drugs were hiked without proof of new benefits, costing the U.S. $1.2 billion in 2022, report finds
During 2022, drugmakers substantially raised prices on eight widely used medicines without any new clinical…
.jpg)
STAT+: Amid fears of superbugs, sales of antibiotics used in food-producing livestock rose last year
Amid fears of superbugs, the sale of medically important antibiotics given to food-producing livestock rose…
STAT+: After sickle-cell screwups, Bluebird Bio’s only option might be a company sale
The approval Friday of Bluebird Bio’s gene therapy for sickle cell disease should have been…
STAT+: Inside Vertex’s decades-long quest to develop a new class of non-opioid painkillers
SAN DIEGO — For decades, the biotech industry has tried — and repeatedly failed —…
Opinion: U.S. medical schools aren’t teaching future doctors about 7.4 million of their patients
Oliver McGowan was 18 years old when he was hospitalized in England with recurrent seizures…
STAT+: A Q&A with Vertex founder Joshua Boger on Casgevy, the biotech industry, and Elon Musk
Vertex Pharmaceuticals made history Friday when it received regulatory approval for a medicine that could…
STAT+: Historic approval of sickle cell gene therapies met with cautious optimism by experts at ASH
SAN DIEGO — News of the Food and Drug Administration’s historic approval of the first…
STAT+: CAR-T, recently used in a lupus patient, helps other autoimmune patients, too, in small study
SAN DIEGO — When the first lupus patient received CAR-T therapy, researchers watched in amazement as…
STAT+: Was CAR-T therapy a bystander or driver of lymphoma? Researchers examine first published case
SAN DIEGO — Researchers on Saturday presented an unusual case of a T cell lymphoma…
Opinion: STAT readers on diagnostic tests, marijuana regulation, and pediatric oncology
STAT now publishes selected Letters to the Editor received in response to First Opinion essays…
STAT+: Vertex gets a win as Colorado board leaves cystic fibrosis drug off a list of unaffordable medicines
In a win for Vertex Pharmaceuticals, a Colorado state board voted not to place the…
STAT+: Tough road ahead for Bluebird Bio despite FDA approval for sickle cell therapy
The Food and Drug Administration’s approval on Friday of two gene therapies for sickle cell…
STAT+: Medicare’s advisory committee isn’t sold on big pay raises for doctors
On Thursday, the Medicare Payment Advisory Commission reviewed Medicare performance data and concluded that despite…
Chronic fatigue syndrome estimated to affect 3.3 million in U.S., more than previously thought: CDC
Health officials on Friday released the first nationally representative estimate of how many U.S. adults…
STAT+: A Q&A with the CEO of CRISPR Therapeutics on a historic approval and the road ahead
Editas Medicine, CRISPR Therapeutics, and Intellia Therapeutics were all started in the 2013-2014 time frame…
Opinion: After living with sickle cell disease for 39 years, I’m both excited and skeptical about the newly approved gene therapies
For 39 years, I have lived with sickle cell disease. As of late, the sickle…
In historic decision, FDA approves a CRISPR-based medicine for treatment of sickle cell disease
The Food and Drug Administration on Friday approved the world’s first medicine based on CRISPR…
Morning Rounds: 3D-printed organs, antimicrobial resistance in Ukraine, and other major health stories of the day
Understand how science, health policy, and medicine shape the world everyday. Sign up for our…
CRISPR is about to make history. Here’s the 5-minute rundown of what to expect
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Pharmalittle: Biden pharma patent proposal spurs fears; Klobuchar questions company behind price spike of lead poisoning antidote
And so, another working week will soon draw to a close. Not a moment too…
Opinion: STAT+: Health care AI requires a new Hippocratic oath
It was no surprise when the Biden administration recently outlined in a broad executive order…
Opinion: Clients bring politics into the therapy room. Here’s what that means for the therapist
“Can I tell you what I really think about what’s going on?” she asks, looking…
STAT+: New proposals for scientific misconduct investigations worry some research universities
Research universities are voicing concerns over some proposed changes to the process for reviewing scientific…
STAT+: Sen. Warren pushes for more data on Medicare Advantage coverage hurdles, denials
A bipartisan group of senators is urging the Biden administration to beef up the amount…
STAT+: Biden proposal targeting pharma patents spurs industry fears and consumer doubts
Will this be a half a loaf? After months of deliberation, the Biden administration on…
CRISPR history, biotech struggles, & a big week for deals
How does the first CRISPR treatment work? Can biotech rebound? And when is $300 million…
In pigs, researchers show ultrasound could be used for 3D printing inside the body
Imagine getting surgery without ever being cut open. Researchers at Duke University and Harvard Medical…
STAT+: Medtronic cancels $738 million acquisition of diabetes tech company EOFlow
Medtronic is no longer buying EOFlow, a Korean maker of wearable insulin pumps. The news…
Senate committee launches bipartisan investigation into private equity ownership of hospitals
The two leaders of the Senate Budget Committee on Thursday launched a bipartisan investigation into…
White House delays menthol cigarette ban, alarming anti-smoking advocates
White House officials will take more time to review a sweeping plan from U.S. health…
Diabetes ‘epidemic’ gets a Senate hearing
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and…
STAT Health News: Abortion ‘companion networks,’ NEJM’s racist past, and other stories you need to read
Understand how science, health policy, and medicine shape the world everyday. Sign up for our…
Eli Lilly’s latest $1.4 billion deal might come unglued
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Pharmalittle: White House takes aim at pharma patents to lower drug prices; Sanofi CEO defends reducing earnings forecast
Top of the morning to you. Gray skies are hovering over the Pharmalot campus right…
Mexico’s activist ‘companion networks’ quietly provide abortion pills and support to U.S. women
TIJUANA, Mexico — Just over a decade ago, when Crystal Pérez Lira needed an abortion,…
Proposal to protect abortion patients’ records faces pushback from Epic, UnitedHealth
At a time when abortion access can vary widely across the U.S., many reproductive health…
STAT+: ‘Learning each other’s language’: FDA, patent office seek to work together to lower drug prices
In 1997, Celgene obtained a key patent for what would become a blockbuster blood cancer…
Opinion: Having a child with complex medical needs is hard enough. Navigating the health care system makes it worse
Many families take for granted the ritual of taking a newborn baby home, car seat…
Sanofi says it has 12 blockbusters in its back pocket. Will investors believe it?
NEW YORK — The top executives at French drug giant Sanofi on Wednesday defended their…
STAT+: To lower drug prices, White House takes new aim at pharma patents
WASHINGTON — The White House is throwing its support behind a controversial authority that allows…
STAT+: AbbVie purchases neuroscience developer Cerevel for $8.7 billion
Abbvie announced Wednesday that it will purchase Cereval Therapeutics and its pipeline of experimental neurological…
New England Journal of Medicine reckons with its racist past and complicity in slavery
The New England Journal of Medicine, the world’s oldest continually published medical journal, publicly reckoned…
STAT+: Stephen Hemsley, UnitedHealth Group board chair, sells nearly $113 million in stock
Stephen Hemsley, the board chair and former CEO of UnitedHealth Group, has sold nearly $113…
Most drugmakers have so far ignored looming FTC deadline to withdraw or amend wayward patents
With 10 days to go, only one company has responded to a demand by the…
STAT+: Using Pap smears for earlier ovarian cancer detection shows promise in small new study
Ovarian cancer owes its often-dismal prognosis to the late stage at which it’s typically discovered….